NEW YORK — As the winter of 2025 settles over the tri-state area and the Jewish community prepares for the festival of Chanukah, a poignant milestone is being marked in the world of public health and communal support. December 2025 marks exactly ten years since the passing of Rochelle Shoretz, the visionary founder of Sharsheret, a national non-profit organization dedicated to supporting Jewish women and families facing breast and ovarian cancer.
In a moving year-end appeal, Shoretz’s sons, Shlomo and Dovid Mirsky—who were mere toddlers when their mother first received her diagnosis—are calling upon the international community to ensure that the "chain" their mother forged remains unbroken. What began as a gathering of five women around a kitchen table in 2001 has transformed into a global movement that now reaches over 275,000 individuals annually.
Main Facts: A Mission Born of Necessity
The story of Sharsheret (Hebrew for "chain") is one of the most significant case studies in modern patient-advocacy history. Founded by Rochelle Shoretz, a former law clerk to U.S. Supreme Court Justice Ruth Bader Ginsburg, the organization was created to fill a glaring void in the healthcare landscape.
When Shoretz was diagnosed with breast cancer at age 28, she found that while medical resources were abundant, culturally specific emotional and psychosocial support was non-existent. For a young Jewish mother, the challenges of cancer were inextricably linked to her religious identity, her role in her family, and the unique genetic risks prevalent within the Ashkenazi Jewish community.
Today, Sharsheret provides a sprawling network of services, including:
- Peer Support Networks: Connecting women with similar diagnoses and life stages.
- The Busy Box: Specialized kits for parents to help young children cope with a mother’s treatment.
- Genetic Counseling: Guidance regarding BRCA1 and BRCA2 mutations.
- Financial Assistance: Subsidies for non-medical costs associated with cancer care.
The 2025 year-end campaign is not merely a fundraising drive; it is a testament to the sustainability of Shoretz’s vision, proving that an organization built on personal vulnerability can evolve into a pillar of institutional healthcare support.
Chronology: From Diagnosis to a Global Movement
2001: The Catalyst
Rochelle Shoretz was a rising legal star when she received her diagnosis. At the time, Shlomo was five and Dovid was three. In the early 2000s, cancer was often a "taboo" subject within many segments of the Jewish community, spoken of in whispers if at all. Shoretz struggled to find a peer who understood the nuances of raising children in a traditional household while undergoing chemotherapy.
The turning point occurred when she met Lauryn Weiser, another young Jewish mother who was slightly further along in her treatment. That single connection—the realization that she was not alone—became the blueprint for Sharsheret.
2001–2015: Building the Chain
Shoretz launched Sharsheret from her dining room table. She recognized that Jewish women faced a unique set of circumstances: a 1-in-40 chance of carrying a BRCA gene mutation (ten times higher than the general population) and a culture deeply rooted in large family gatherings and communal life that could feel isolating during illness.
Under her leadership, the organization gained national recognition, eventually becoming a member of the Federal Advisory Committee on Breast Cancer in Young Women. Despite her own recurring health battles, Shoretz remained the face of the organization until her death on May 31, 2015, at the age of 42.
2015–2025: A Decade of Exponential Growth
Following Shoretz’s passing, many wondered if the organization would maintain its momentum. The past decade has answered that question with resounding growth. Sharsheret expanded its reach to include ovarian cancer programs, increased its focus on Sephardic and Mizrahi Jewish communities, and integrated advanced digital health tools to provide remote support to isolated patients.
In 2025, the organization stands as an international powerhouse, having transitioned from a founder-led startup to a professionally managed global entity that remains true to its grassroots origins.
Supporting Data: The Statistics of Impact
The necessity of Sharsheret is underscored by sobering medical data. Research consistently shows that members of the Ashkenazi Jewish community carry a significantly higher risk for hereditary breast and ovarian cancers.
- Genetic Predisposition: Approximately 1 in 40 Ashkenazi Jews carries a mutation in the BRCA1 or BRCA2 genes. This compares to roughly 1 in 400 in the general population.
- Annual Reach: As of 2025, Sharsheret provides direct services to over 275,000 people. This includes patients, family members, and healthcare professionals seeking cultural competency training.
- The "Busy Box" Metric: Since its inception, thousands of "Busy Boxes" have been shipped to families. These kits contain age-appropriate toys, books, and resources designed to facilitate communication between parents and children during treatment, a program Shlomo and Dovid Mirsky personally credit with helping them navigate their childhood.
- Educational Outreach: Sharsheret partners with over 500 synagogues, university campuses, and community centers annually to provide life-saving education on genetic testing and early detection.
Official Responses: Voices of the Legacy
In their joint statement, Shlomo and Dovid Mirsky reflected on the bittersweet nature of this tenth anniversary.
"It’s hard to believe it’s been 10 years since Mom’s passing," the brothers stated. "She has missed so many milestones—from graduations to grandchildren to Sharsheret reaching incredible heights. We were personally served by Sharsheret, which provided life-changing assistance to our family during Mom’s fight against cancer. As young children, receiving Sharsheret’s Busy Box helped distract us from the difficult realities of Mom’s cancer treatments."
The Mirsky brothers emphasized that their mother’s legacy is not just in the past, but in the future they are helping to fund. "What started as five women around our dining room table has turned into an international movement. We know that thanks to your generosity, Mom is looking down with pride as we build a healthier and brighter future for the next generation."
Executive leadership at Sharsheret noted that the year-end campaign is vital for maintaining the organization’s "no-barrier" policy. Unlike many support services, Sharsheret provides its programs free of charge to patients and their families, relying entirely on the philanthropy of the community to sustain its multi-million dollar annual budget.
Implications: The Future of Culturally Competent Care
The evolution of Sharsheret over the last quarter-century has broader implications for the global healthcare system. It serves as a primary model for "culturally competent care"—the idea that medical outcomes are improved when a patient’s cultural, religious, and familial context is integrated into their support system.
1. Breaking the Taboo
The most significant cultural implication of Sharsheret’s work has been the destigmatization of cancer. By bringing the conversation to the "dining room table" and eventually to the pulpit of synagogues, Shoretz effectively dismantled the wall of silence that once surrounded "the illness" in religious communities. This has led to higher rates of genetic screening and earlier diagnoses, which directly correlate to higher survival rates.
2. The Patient-Led Revolution
Sharsheret’s success has inspired other minority groups to create similar niche support networks. The organization demonstrated that patients are not just passive recipients of care but can be the architects of systemic change. In 2025, Sharsheret’s model is being studied by public health experts as a blueprint for addressing health disparities in other ethnic and religious enclaves.
3. The Multi-Generational Mission
The involvement of Shlomo and Dovid Mirsky highlights a shift in the organization’s narrative. It is no longer just about those currently fighting cancer; it is about the "survivors of the survivors." By focusing on the children and grandchildren of those affected, Sharsheret is addressing the long-term psychological and genetic implications of cancer across generations.
Conclusion: A Chain of Hope
As the 2025 year-end giving season reaches its peak, the "Chain" that Rochelle Shoretz started remains a lifeline for thousands. The appeal by her sons serves as a reminder that while medical science seeks the cure, communal support provides the strength to endure the search.
The Mirsky brothers concluded their appeal with a nod to the upcoming holiday: "With sincere gratitude and best wishes for a happy and healthy Chanukah." In the context of Sharsheret, the "Festival of Lights" takes on a deeper meaning—representing the light of knowledge, the warmth of community, and the enduring flame of a mother’s legacy that refused to be extinguished by her passing.
For those looking to contribute to this ongoing mission, the organization has directed donors to their dedicated portal at link.Sharsheret.org/EOY, ensuring that the next ten years of the "chain" are as impactful as the last.
About the Author
